Skip to content
Review Open access

APC alterations in papillary thyroid carcinoma: molecular mechanisms, clinical implications, and future perspective

Jul 2026 · Journal of Diabetes and Metabolic Disorders · Vol 25 · 0 citations · 122 references
Medicine

TL;DR

The definite clinical significance of APC mutations in PTC emergence is not fully understood, and additional prospective and translational studies are required to elucidate their biological and clinical advantages in diagnosis, prognosis, targeted therapy, and individualized patient management.

Read PDF

Similar papers

Review Open access Aug 2026

Signaling pathways and targeted therapy in high-risk refractory thyroid cancer: From bench to bedside (Review)

The present review systematically reviewed recent epidemiological trends in thyroid cancer and provided an in-depth exploration of the molecular regulatory mechanisms of key signaling pathways, including MAPK, PI3K/AKT, Janus kinase/STAT, WNT/β-catenin and NF-κB, along with their roles in the pathogenesis and progressi...

Jian Wang, Zhi Liu, Qing Zhang et al. · 0 citations
Open access Sep 2026

Clinical Relevance and Regulatory Mechanisms of LINC01521 in Papillary Thyroid Carcinoma.

OBJECTIVE Papillary thyroid carcinoma (PTC) is a well-differentiated malignancy derived from thyroid follicular epithelial cells. This study explores the functional role and underlying mechanisms of LINC01521 in PTC, aiming to provide new strategies to improve prognostic assessment and survival rates for PTC. METHODS...

Xiaotao Duan, Zai-Kai Lin · 0 citations
Review Open access Aug 2026

Aberrant Signal Transduction Pathways in Pancreatic Ductal Adenocarcinoma: Current Perspectives on Molecular Targets

The review discusses the key genetic drivers of pancreatic carcinogenesis, including KRAS, TP53, CDKN2A, SMAD4, and BRCA1/2, and emphasizes the role of these genes as therapeutic biomarkers for the development of targeted molecular therapy.

S. Kaviya, G. Sivakumar, P. Anandhasankar · 0 citations
Editorial Open access Sep 2026

Editorial: Targeting the Wnt/β-catenin signaling pathway in cancer, volume II

Together, these studies emphasize that Wnt/ b -catenin signaling is controlled at multiple regulatory levels and cellular compartments, supporting context-speci c and biomarker-guided therapeutic strategies.

S. Patergnani, D. Buchsbaum, G. Piazza et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.